EN
EN
Zhongjia Biomedical's serum-free hematopoietic stem cell basal medium has officially received a
2026.7.23 View Details
MLD is mainly divided into three subtypes according to age of onset; the earlier the onset, the fast
2026.6.16 View Details
MLD follows an autosomal recessive inheritance pattern, which can be briefly explained as follows: O
2026.6.16 View Details
The clinical research project of CD73+NK cell subpopulation (ZJ-S-0016) for cognitive rehabilitation
2026.5.22 View Details
A breakthrough year for global iPS medical application, as China's 'medium power' breaks through dec
2026.3.18 View Details
Zhongjia Biomedical leads the drafting of China's first group standard for the preparation of human
2025.6.27 View Details